NCT05814965

Brief Summary

While cross-sectional studies have reported a significant association between diabetes and Apical Periodontics, prospective studies are scarce. This will be the first prospective interventional study to explore the cause-and-effect relation between AP and diabetes by assessment of levels of inflammatory markers in a longitudinal setting. Periapical healing in diabetics and nondiabetics will be compared after root canal treatment to evaluate the role of various physical and metabolic attributes on endodontic outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
280

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

April 5, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

1.7 years

First QC Date

April 3, 2023

Last Update Submit

April 3, 2023

Conditions

Keywords

Apical PeriodontitisDiabetes mellitusHigh sensitivity C-reactive proteinTumor necrosis factor-alphaInterleukinGlycated hemoglobin

Outcome Measures

Primary Outcomes (5)

  • PAI SCORE

    PERIAPICAL INDEX RADIOGRAPHIC EVALUATION

    12 MONTHS

  • Interlukin 1B

    INFLAMMATORY MARKER BY ELISA KIT

    12 MONTHS

  • IL 6

    ESTIMATION OF NFLAMMATORY MARKER BY ELISA KIT

    12 MONTHS

  • TNF -ALPHA

    ESTIMATION OF NFLAMMATORY MARKER BY ELISA KIT

    12 MONTHS

  • hs-CRP

    ESTIMATION OF NFLAMMATORY MARKER BY ELISA KIT

    12 MONTHS

Study Arms (4)

Diabetic patients with Apical periodontitis

EXPERIMENTAL

Diabetic patients with Apical periodontitis received Endodontics treatment in form of Root canal treatment and assessment of inflammatory and metabolic markers

Procedure: endodontic treatment in the form of root canal treatment

Healthy patients with Apical periodontitis

EXPERIMENTAL

systemically healthy participants patients with Apical periodontitis received Endodontics treatment in the form of root canal treatment and assessment of inflammatory markers

Procedure: endodontic treatment

Diabetic patients with out Apical periodontitis

ACTIVE COMPARATOR

systemic inflammatory markers along with metabolic markers will be assessed

Diagnostic Test: inflammatory markers will be assessed along with metabolic markers assessment

Healthy participants without Apical periodontitis

ACTIVE COMPARATOR

systemic inflammatory markers will be assessed

Diagnostic Test: assessment of inflammatory marker

Interventions

Patients will receive endodontic treatment, and inflammatory markers will be assessed

Also known as: RCT
Diabetic patients with Apical periodontitis

Patients will receive endodontic treatment in the form of root canal treatment, and inflammatory markers will be assessed along with metabolic markers assessment

Healthy patients with Apical periodontitis

assessment of inflammatory markers

Healthy participants without Apical periodontitis

inflammatory markers will be assessed along with metabolic markers assessment

Diabetic patients with out Apical periodontitis

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients 30-55 year age group with minimum 20 natural teeth, with pulp necrosis confirmed by cold test and electric pulp test and radiographic evidence of periapical radiolucency with PAI score of ≥3 (24) or more in at least one mature tooth.
  • control in the systemically healthy group will be selected to match participants in terms of age, sex, and BMI.
  • control for participants with type 2 DM will be selected to additionally match with glycaemic control, drugs and dietary measures apart from other physical attributes.

You may not qualify if:

  • Patients with clinical diagnosis of moderate to severe periodontitis (≥6 sites with probing depth ≥5 mm at separate teeth, with attachment loss and radiographic alveolar bone loss), Patients with immunosuppression, pregnancy, conditions requiring prophylactic antibiotics prior to dental treatment, bleeding disorders, medical conditions that may affect study participation (e.g., unstable cardiovascular disease) and chronic inflammatory conditions like rheumatoid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIDS

Rohtak, Haryana, 124001, India

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Periapical PeriodontitisDiabetes Mellitus

Interventions

Endodontics

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPeriapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Intervention Hierarchy (Ancestors)

Dentistry

Study Officials

  • SANJAY TEWARI

    POST GRADUATE INSTITUTE OF DENTAL SCIENCES,ROHTAK

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 280 patients 140 in DM (70 each with AP and 70 without AP) and 140 Systemically healthy (70 each with AP and 70 without AP)will be enrolled and compared for systemic markers .Subjects with AP will be provided Endodontics treatment and levels of markers will be assessed one year after Endodontics treatment. markers.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2023

First Posted

April 18, 2023

Study Start

April 5, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

April 18, 2023

Record last verified: 2023-04

Locations